Mereo BioPharma Group plc (LON:0A9G)

Mereo BioPharma Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 14, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	349	254	73	128	177	49
Market Cap Growth	257.21%	249.41%	-43.40%	-27.46%	264.76%	-
Enterprise Value	291	221	14	37	162	45
Last Close Price	2.31	1.85	0.62	1.20	-	-
PE Ratio	-	-	-	13.66	-	-
PS Ratio	631.32	32.34	-	4.77	-	-
PB Ratio	8.70	6.40	1.70	1.98	-16.14	1.60
P/TBV Ratio	8.80	6.54	1.70	2.74	-	-
EV/Sales Ratio	550.05	28.17	-	1.38	-	-
Debt / Equity Ratio	0.09	0.12	0.30	0.19	-1.20	0.81
Asset Turnover	-	0.14	-	0.39	-	-
Quick Ratio	5.83	6.38	2.89	7.66	3.23	0.94
Current Ratio	6.10	6.72	3.09	7.92	3.47	1.02
Return on Equity (ROE)	-62.11%	-57.81%	-53.63%	34.85%	-1294.27%	-95.43%
Return on Assets (ROA)	-	-23.57%	-28.67%	-13.82%	-31.43%	-31.85%
Return on Capital (ROIC)	-28.94%	-27.52%	-34.13%	-24.29%	-62.09%	-38.57%
Earnings Yield	-9.68%	-9.11%	-48.22%	7.32%	-67.72%	-54.22%
FCF Yield	-4.78%	-6.53%	-55.78%	-3.32%	-11.74%	-71.51%
Buyback Yield / Dilution	-12.61%	-9.33%	-8.63%	-63.82%	-279.04%	-25.69%
Total Shareholder Return	-12.61%	-9.33%	-8.63%	-63.82%	-279.04%	-25.69%

Source: S&P Capital IQ. Standard template. Financial Sources.